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Summary
Numerous studies using gastric bypass rat models have 
been recently conducted to uncover underlying physi-
ological mechanisms of Roux-en-Y gastric bypass. Re-
flecting on lessons learned from gastric bypass rat 
models may thus aid the development of gastric bypass 
models in mice and other species. This review aims to 
discuss technical and experimental details of published 
gastric bypass rat models to understand advantages 
and limitations of this experimental tool. The review is 
based on PubMed literature using the search terms ‘ani-
mal model’, ‘rodent model’, ‘bariatric surgery’, ‘gastric 
bypass’, and ‘Roux-en-Y gastric bypass’. All studies pub-
lished up until February 2011 were included. 32 studies 
describing 15 different rat gastric bypass models were 
included. Description of surgical technique differs in 
terms of pouch size, limb lengths, preservation of the 
vagal nerve, and mortality rate. Surgery was carried out 
exclusively in male rats of different strains and ages. 
Pre- and postoperative diets also varied significantly. 
Technical and experimental variations in published 
gastric bypass rat models complicate comparison and 
identification of potential physiological mechanisms in-
volved in gastric bypass. In summary, there is no clear 
evidence that any of these models is superior, but there 
is an emerging need for standardization of the procedure 
to achieve consistent and comparable data.
Introduction
Currently, the most effective therapy for morbid obesity is 
bariatric surgery [1, 2] with Roux-en-Y gastric bypass (gastric 
 bypass) being the most common operation performed [3]. 
Gastric bypass has been shown to ameliorate or even cure 
obesity-related comorbidities such as type 2 diabetes or sleep 
apnea [1, 4]. The physiological mechanisms by which gastric 
bypass surgery works are not yet fully understood. The suc-
cess of gastric bypass was previously attributed to mechanical 
restriction through reduction of gastric volume as well as calo-
rie malabsorption secondary to the bypass of the duodenum 
and proximal jejunum [5]. The emerging consensus is that the 
gastric bypass (fig. 1) is an operation consisting of at least 
5 components [6, 7]: i) reduction of stomach size; ii) exclusion 
of stomach and first part of small bowel from nutrients; iii) 
bile flow alteration; iv) earlier contact of nutrients with mid 
gut; and v) disruption of gastric branches of the vagal nerve. 
These components act most likely in concert to impact on gas-
trointestinal and central neuroendocrine signaling leading to 
alterations in energy homeostasis [8–10]. Mechanisms contrib-
uting to postoperative body weight loss may include reduced 
hunger and increased satiation [9], increased energy expendi-
ture [10, 11], altered food preference [10, 12, 13], altered insu-
lin secretion and increased insulin sensitivity [14–16]. The rel-
ative impact of each particular component remains unclear.
During the last 2 decades, numerous studies using rats have 
been carried out to investigate physiological changes after 
gastric bypass (table 1). The gastric bypass rat model is a valu-
able tool as it closely mimics the time profile and magnitude 
of human weight loss [14, 15, 17–23] and allows researchers to 
control and manipulate critical anatomic and physiologic fac-
tors. Consequently, there is a wide array of rat gastric bypass 
models available in the literature (table 1). In addition, gastric 
bypass mouse models have attracted major interest to further 
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elucidate physiological changes for example in knock-out ani-
mals [24]. Thus far, only duodenojejunal exclusion models in 
mice have been published [24–27], most likely because gastric 
bypass mouse models are technically demanding [27]. Reflect-
ing on the lessons learned from gastric bypass rat models may 
help to develop mice and other models in the future. This re-
view therefore aims to summarize and discuss technical and 
experimental details of gastric bypass rat models available in 
the literature to highlight the advantages and limitations of 
the current models. 32 studies identified by performing a 
PubMed literature search (www.ncbi.nlm.nih.gov/pubmed/) 
using the search terms ‘animal model’, ‘rodent model’, ‘bariat-
ric surgery’, ‘gastric bypass’, and ‘Roux-en-Y gastric bypass’ 
were included. All studies were published  before February 
2011 and described a total number of 15 different rat models 
of gastric bypass.
Surgical Principles of Roux-en-Y Gastric Bypass
The Roux-en-Y gastric bypass procedure in humans was first 
described by Mason et al. [28] in 1967. The procedure con-
sists of a small gastric pouch and the bypass of the proximal 
small bowel (fig. 1a). The former was initially labeled as the 
restrictive component because of the smaller storage capacity 
in the pouch and the limitation of nutrient flow through the 
gastro jejunostomy through which ingested foods are emptied 
from the pouch into the jejunum (‘Alimentary limb’, length 
75–250 cm). The latter was initially considered the malab-
sorptive part of the gastric bypass operation as the stomach 
remnant, the duodenum, and the proximal jejunum are by-
passed by nutrients. This bypassed part of the gastrointestinal 
tract forms the  so-called ‘biliopancreatic limb’ because bile 
acids as well as pancreatic enzymes are secreted into the duo-
denum. The  biliopancreatic limb is joined downstream to the 
alimentary limb by a jejunojejunal anastomosis to form the 
‘common channel’ delaying mixture of ingested food with 
bile and  digestive enzymes (fig. 1a).
Differences in Surgical Technique of Published  
Gastric Bypass Rat Models
Pouch
The gastric bypass operation in humans creates a small gastric 
pouch (20–50 ml) with very limited food storage capacity [29, 
30]. Mason et al. [5] reported that a large pouch size causes 
insufficient weight loss or weight regain and therefore sug-
gested a pouch size of less than 50 ml. A negative correlation 
between pouch size and body weight loss after gastric bypass 
has also been described by Roberts et al. [31], but this remains 
controversial [29, 30]. The creation of a small gastric pouch in 
rats is technically demanding and a variety of different tech-
niques has been described (table 1). The pouch size of the 
 reported gastric bypass models in rats ranges from 5% (fig. 1a) 
to more than 20% (fig. 1b) of the initial stomach size [17, 32, 
33]. Most authors transect the stomach by using stapler 
 devices or microsurgical scissors (table 1). To avoid bleeding 
from the stomach, the stapler line is sown over in some 
 models [21, 34]. The ligation of left gastric vessels can help to 
avoid bleeding, but can cause ischemia of the remnant stom-
ach [21, 34]. Therefore, gentle mobilization of the main vessel 
by cauterizing tributaries and branches without dissection or 
ligation has been reported [17, 18], while Tichansky et al. [34] 
performed a partial resection of the remnant stomach to avoid 
necrosis. 
In contrast to gastric bypass in humans, most of the pub-
lished rat gastric bypass models preserve a stomach pouch of 
at least 20% of the original volume (table 1). Gastric bypass 
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Fig. 1. Schematic illustration of gastric bypass models using a gastric 
pouch of less than 5% (a) and of about 20% (b) of the original stomach 
size. 
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Bile Flow Alterations
The altered nutrient flow and in particular the altered bile 
flow after gastric bypass may also contribute to metabolic 
changes [47–49]. It should be emphasized that contrary to the 
traditional view bile does not function simply as a fat solubi-
lizer, but also influences cholesterol and glucose metabolism 
by acting on nuclear receptors [50]. Bile has also been shown 
to modulate energy expenditure by stimulating brown adipose 
tissue and skeletal muscle via activation of the G-protein- 
coupled receptor TGR5, which is also expressed on the sur-
face of enteroendocrine L-cells [49, 51]. Alterations in bile 
acid metabolism have not been addressed in any of the re-
viewed rodent studies, but given the differences in limb 
lengths between the different bypass rat models, it seems 
plausible that bile acid metabolism may be altered. 
Gut Hormone Alterations
Altered levels of gut hormones after gastric bypass to humans 
have been previously reported [52, 53]. However, it is unclear 
whether bypassing the hormonally active duodenum and 
proximal jejunum or increasing the delivery of undiluted bile 
and undigested foods to the distal small bowel, or both, stimu-
late the enteroendocrine L-cells to secrete gut hormones such 
as peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) 
[49, 54]. Elevated levels of PYY and GLP-1 lead consequently 
to increased satiety and reduced hunger thought to be through 
actions on the hypothalamic arcuate nucleus and paraven-
tricular nucleus, respectively [55, 56]. PYY, released post-
prandially from the distal gastrointestinal tract, decreases 
 expression of the orexigenic hypothalamic neuropeptide Y 
(NPY) and inhibits food intake. Peripheral administration of 
PYY3–36 and GLP-1 in humans and rodents reduces food 
 intake [57, 58]. GLP-1 also acts as an incretin-promoting 
 postprandial insulin release [59] and improves pancreatic cell 
function [60]. Some but not all of the reported rat models of 
gastric bypass reported alterations in gut hormone levels. 
Upon further scrutiny, elevated levels of PYY and GLP-1 
were found in both fasting [17] and fed rats [17, 61–63] after 
gastric bypass (table 2). 
So far, ghrelin is the only known orexigenic enteropeptide 
[64, 65]. Ghrelin is mainly produced from the fundus of the 
stomach and the oral small intestine [52, 66]. Ghrelin might 
play a role in meal initiation as its levels are increased prior to 
a meal [67]. Postprandially, ghrelin levels are suppressed pro-
portional to the caloric content of the ingested foods [68]. 
Available data on ghrelin levels after gastric bypass in humans 
are inconclusive, as decreased [52, 69], unchanged [8, 9], or 
even increased [70, 71] levels have been observed postopera-
tively in humans. Similarly, ghrelin levels after gastric bypass 
in rats also show great variations [33, 72, 73]. Post operative 
alterations in gut hormone levels after gastric bypass in rats 
are summarized in table 2. The effect of gastric bypass surgery 
on gut hormone levels has been systematically reviewed else-
where [6]. 
rats with a pouch of 20% or more of the original stomach size 
retain ingested contrast medium in their pouch long after 
 ingestion has stopped [23]. Thus, the pouch may retain stor-
age capacity, consequently resulting in a different physiolo-
gical state compared to human gastric bypass. Other gastric 
bypass rat models reported a pouch size between 5% [17, 18] 
and 10% [35] demonstrating reductions in food intake varying 
from little [35] to significant [17, 18]. To investigate whether 
the small pouch causes restriction, we compared the food in-
take of gastric bypass rats after a 1-day starvation period. 
Gastric bypass rats were able to eat significantly more than ad 
libitum fed sham-operated rats (unpublished data) suggesting 
that the restrictive component may be overestimated and that 
reduced motivation may be more important than physical 
ability to eat after gastric bypass. However, the food intake of 
gastric  bypass rats seems to be reduced independently of the 
gastric pouch size [17, 21, 34, 35], although meal size became 
smaller while animals ate more frequently [18, 36]. 
Limb Length
The impact of the different intestinal limb lengths in terms of 
body weight loss in humans remains controversial and some 
authors still favor an alimentary limb length (75–150 cm) de-
pendent on the preoperative body weight [37–39]. Rand-
omized controlled trials suggest that a length of the alimen-
tary limb between 75 and 150 cm does not predict body weight 
loss or the improvement of obesity-related comorbidities in 
humans after gastric bypass [37, 40–43]. In contrast, Pinheiro 
et al. [44] have shown that gastric bypass with an alimentary 
limb of 250 cm may be superior for type 2 diabetes, lipid 
 disorders, and body weight loss in the short term. Caloric mal-
absorption may account for 6–11% of the total reduction in 
energy absorption after long limb Roux-en-Y gastric bypass in 
humans [45]. A longer alimentary limb may thus introduce 
 caloric malabsorption and lead to greater body weight loss.
There are considerable differences in the limb lengths 
across the available gastric bypass rat models with an alimen-
tary limb varying between 10 and 50 cm, the biliopancreatic 
limb length ranging between 10 and 40 cm and a common 
channel between 18 and 34 cm (table 1). Significant caloric 
malabsorption has however been excluded by bomb calorim-
etry even in the short common channel (25 cm) gastric bypass 
models eating normal low fat chow [18, 35]. In animals fed a 
high fat chow, a small amount of malabsorption for fat has 
been demonstrated even in models with a long common chan-
nel (approximately 50 cm) [23]. Thus, malabsorption may re-
late more to dietary fat content than to limb length. Guiarro 
et al. [19] reported a significantly increased fecal output ac-
companied by malabsorption of fat in normal chow fed gastric 
bypass rats with a biliopancreatic limb of 30 cm and a com-
mon channel of 18 cm, which is reminiscent of a malabsorp-
tive biliopancreatic diversion rather than of a Roux-en-Y gas-
tric bypass [46]. 
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from stretch and chemoreceptors which are activated by the 
presence of nutrients in the stomach and the intestine, respec-
tively [79]. Furthermore, gut hormone signaling and the vagal 
nerve are closely intertwined as the release of gut hormones 
as well as their effects is influenced by vagal signals [80]. Thus, 
serum levels of pancreatic polypeptide have been used to 
measure vagal efferent function [81, 82]. The blockade of 
vagal impulses reduces ghrelin levels in humans [83], and ex-
ogenous ghrelin administration to vagotomized patients does 
not stimulate food intake [84]. Satiety-inducing gut hormones 
such as PYY and GLP-1 may also act via afferent vagal fibers 
[77]. Vagal afferents are relayed to central nervous system 
structures, including the nucleus tractus solitarii which is 
known to be important in mediating food intake [85]. Addi-
tionally, vagal efferent signals have been shown to regulate 
the motility of the gastrointestinal tract directly through 
cholinergic signaling [86]. To date, the relevance of the vagal 
nerve for body weight after gastric bypass is incompletely un-
derstood [71, 77, 87]. We demonstrated previously that pre-
serving vagal fibers of the dorsal vagal trunk during the gas-
tric bypass operation may lead to greater and more sustained 
body weight loss in rats [17]. This is consistent with previous 
Postoperative Changes in Gut Morphometry
Hypertrophy of the small bowel has only been described after 
biliopancreatic diversion in humans [74], but not after gastric 
bypass. In contrast, a considerable mucosal and muscle hyper-
trophy of the alimentary limb and the common channel has 
been described in rats [18, 63, 75, 76]. This observation seems 
to be independent of the alimentary limb (10–50 cm) and 
common channel (20–50 cm) length [18, 63, 75, 76]. These 
findings are in accordance with elevated levels of GLP-2 after 
gastric bypass, which has been shown to promote cellular divi-
sion of ileal mucosal cells and to inhibit apoptosis [63, 75]. 
Thus, the epithelial cell proliferation described endows the 
gut with the capacity to restore the absorptive surface area, 
thereby limiting malabsorption [75]. The gut hypertrophy may 
also partly explain the increased energy expenditure after 
 gastric bypass in rats [18, 23]. 
Vagus
The vagal nerve plays an important role in the regulation of 
food intake and body weight [77]. Chronic vagal nerve stimu-
lation decreases sweet craving, food intake, and body weight 
gain in minipigs [78]. Vagal afferents transmit information 
Table 2. Body weight loss, food intake and gut hormones of gastric bypass models
Institution Body weight, % Weight plateau Food intake,% Hormonal response (fasting)
< 2 weeks > 2 weeks
Aphramian [72] –15.1 – – – ghrelinB
Berthoud [22, 36, 62] –20 23 yes –20 GLP-1(B)B, PYY(C)B, ghrelin (C)C, 
GIP(C)C, leptin? [3]
Cooney [61, 93, 110] –9/–6 [6, 7]
–20/16 [5]
–13/–8
–26
yes
yes
–
–40/–15 [5]
GLP-1(C)B, PYY (C)B, GIP(C)C, 
glucagon(C)C [6]
Inhoe [89] –17 0 no NR NR
Kaplan [23, 111] –17 –20 to 30 yes –16.8 ghrelin?
Le Roux [17, 18, 75, 100] –8 to 11 –10 to 15 yes –15 to 20 GLP-1(B)B [12]; PYY(B)B [12], GLP-2(B) [14]
Li [112] NR NR NR NR NR
Xu [90, 94, 117, 118] –18 –9 no –25 leptin? [30]
Meguid [19, 21, 73, 113, 114] –18
–25
–25
–34 (–14)
yes
yes 
–23 (0) NR
ghrelinC, CCKB(3)C(13), PYYB, leptin?, 
GLP-1C [20], 
adiponectin?(C) [17, 18, 20]
Murr [115, 116] NR NR NR NR NR
Taqui [63] –21.6 – – – PYYB, GLP-2B
Tichansky [34, 108] –20
–15
–11
–5
no
no
?
NR
– [25]
– [26]
Wang [33] NR B no NR ghrelin(?)?; leptin?
Young [119] 8 NR NR –30 NR
GLP-1/2 = Glucagon-like peptide 1/2; PYY = peptide YY; GIP = gastric inhibitory polypeptide; CCK = cholecystokinin; NR = not reported.
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Diet and Age
Most of the available rat studies have been carried out on 
obese animals. Some strains used are genetically obese (e.g. 
the ZDF rats) and were fed normal chow (table 3). In other 
studies, obesity was induced by feeding high fat diets (table 3) 
aiming to induce a metabolic syndrome similar to that found 
in humans [99]. However, there was variability in both the 
composition of the high fat diets and in the time period in 
which they were consumed (ranging from 6 to 20 weeks). Nor-
mal chow has also been used to induce obesity, although this 
approach takes longer [8, 17, 18, 75, 100]. The age of the ani-
mals may also impact on metabolic rate and other more subtle 
physiological parameters [101]. Postoperatively, the rats were 
fed different diets (table 3). Some groups changed from a high 
fat preoperative diet to a low fat diet after surgery. Thus, the 
change in diet itself can also affect body weight. 
Food Intake and Body Weight
Gastric bypass in humans induces and sustains a body weight 
loss of approximately 15–30% [4]. Most of the body weight 
loss occurs during the first postoperative year [102] partly 
due to reduced food intake, altered food preference, and 
 increased energy expenditure [9–11]. Physiological weight 
 regain occurs after gastric bypass, but an average weight loss 
of 25% has been reported at 15 years after the operation 
[102]. Most gastric bypass rat models also induce a significant 
reduction in food intake and body weight (table 2). Some 
models are characterized by maintenance of the low body 
weight [17, 18] while others display a constant weight regain 
paralleling the body weight of sham-operated controls shortly 
after gastric bypass [19]. However, body weight loss is usually 
accompanied by a greater reduction of subcutaneous and 
 visceral fat mass compared to the lean body mass loss [18, 19, 
36, 61, 90]. Thus, animals display similar changes to humans 
in terms of body composition after gastric bypass-induced 
weight loss. 
Immediate delivery of food to the small bowel may be 
more important than the size of the pouch to explain the ob-
served reduced food intake [103]. Prompt pouch emptying 
seems to predict body weight loss after gastric bypass [104], 
but delayed gastric empting and a prolonged intestinal tran-
sit time has also been reported after gastric bypass [23, 73]. 
As mentioned above, the different components of the bypass 
operation lead to alterations of a complex enteroendocrine 
and neuroendocrine response [85], and reduction of food 
 intake might be related to postoperatively increased entero-
hormones like PYY or GLP-1 inducing satiety after gastric 
bypass. In this respect, le Roux et al. [9] showed that post-
prandial PYY and GLP-1 responses were attenuated in pa-
tients with poor weight loss after gastric bypass, which was 
associated with increased appetite compared to patients with 
good weight loss. Meguid et al. [105] showed that postopera-
tive weight regain relates to a decreased PYY/leptin ratio in 
rats. 
reports showing that the ablation of the vagal-brainstem-hy-
pothalamic pathway attenuates the inhibitory effects of PYY 
and GLP-1 on food intake [88]. In contrast, Wang and Liu 
[33] observed greater initial weight loss after total vagotomy 
in gastric bypass rats, but the weight loss difference was not 
sustained in the long term. 
Mortality Rate
Mortality rates after gastric bypass are rarely reported but 
seem to range from 0 to 35% (table 1). Reported mortality was 
due to anastomotic leakage or stenosis [17, 21, 76, 89], bleed-
ing after transecting of the stomach [21, 76], compromising of 
mesenteric vessels due to intussuseption or internal hernia [17, 
90], wound dehiscence[90], intraoperative death or narcotic 
accident [21, 22], and persistent weight loss leading to compro-
mised animal welfare [76]. Differences may be due to surgical 
learning curves. Technical aspects such as type of anastomosis 
(end-to-side vs. side-to-side), suturing (interrupted vs. continu-
ous), using a stapler device, pouch size, preservation of the 
vagal nerve, operation time, antibiotics, type of general an-
esthesia and analgesia do not predict the surgical outcome. 
Furthermore, it can be hypothesized that the perioperative 
diet may also impact on the mortality rate. As a result, some 
authors prefer to give liquid diets to the animals postopera-
tively (table 3), although no data has been presented to sug-
gest that this improves immediate postoperative mortality. 
Strains
Apart from the differences in operative techniques, several 
different strains of rats have been used. Their specific char-
acteristics haven been published elsewhere (Wistar rat [91], 
Sprague-Dawley (SD) rat [91], Fischer 344 rat [89, 92, 93], 
Levin Sprague-Dawley (LSD) rat [23], Osborne Mendel 
(OM) rat [23], Otsuka Long-Evans Tokushima Fatty 
(OLETF) [91, 93] rat, Long-Evans Tokushima Fatty (LETO) 
rat, Zucker Diabetic Fatty (ZDF) rat [90, 91, 94], and Goto 
Kakizaki (GK) rat [91]). The applicability of the different 
available rat strains in the field of bariatric surgery research 
has been discussed in a separate review by Mistry et al. [91]. It 
is reasonable to assume that the choice of rat strain may 
 directly impact on the metabolic findings. Moreover, each rat 
strain may have a very specific and therefore different capac-
ity to cope with surgical trauma.
Sex
Approximately 80% of patients undergoing bariatric surgery 
are female [4]. In contrast, all available rat studies being per-
formed so far have used male animals exclusively (table 3). 
This gender bias may have practical reasons as male rats are 
known to gain weight faster than females [95, 96]. Another 
general advantage is the absence of hormone alterations dur-
ing the estrous cycle. Female rats have an estrous cycle of 
4 days, which is therefore likely to affect food intake and 
 potentially the metabolic outcome [95, 97, 98]. 
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pass. The relative contribution of these components and their 
interaction is not yet known. The variety in available rat 
 gastric bypass models makes it difficult to identify specific 
physiological mechanisms involved in gastric bypass. It seems 
plausible that the different rat models of gastric bypass 
achieved the same phenotype of weight loss by combining 
very different components of what is perceived to constitute 
a gastric bypass. Thus, there is an emerging need for stand-
ardization of the procedure to achieve consistent and com-
parable data, but thus far there is no evidence that any par-
ticular model is superior. 
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The absence of compensatory increased appetite after gas-
tric bypass-induced weight loss has been intriguing as volun-
tary weight loss usually leads to weight regain through in-
creased appetite [106]. Food preference changes to low-calo-
rie dense foods in humans [107] and rodents after gastric by-
pass [22, 93, 108] also play a role. Chronic caloric deprivation 
is usually accompanied by a decrease in resting energy ex-
penditure as the organism attempts to conserve energy to en-
hance survival [106]. Interestingly, energy expenditure has 
been shown to increase in humans [10, 109] and rodents [18, 
23] after gastric bypass.
Conclusion
There is a great variety of gastric bypass rat models differing 
in pouch size, limb length, and preservation of the vagal 
nerve. Furthermore, gastric bypass has been performed in 
different rat strains at different ages on different diets. 
 Nevertheless, the human phenotype in terms of weight loss 
and food intake has been successfully mimicked by most rat 
gastric  bypass models. Several components acting in concert 
lead to the observed physiological changes after gastric by-
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